PharmaEngine Price To Book vs. Price To Sales

4162 Stock  TWD 86.20  1.20  1.37%   
Based on the measurements of profitability obtained from PharmaEngine's financial statements, PharmaEngine may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess PharmaEngine's ability to earn profits and add value for shareholders.
For PharmaEngine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PharmaEngine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PharmaEngine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PharmaEngine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PharmaEngine over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between PharmaEngine's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaEngine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaEngine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PharmaEngine Price To Sales vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PharmaEngine's current stock value. Our valuation model uses many indicators to compare PharmaEngine value to that of its competitors to determine the firm's financial worth.
JavaScript chart by amCharts 3.21.156712176065414147414247434162 0100200300400500600700 024681012
PharmaEngine is rated fourth in price to book category among its peers. It is rated below average in price to sales category among its peers fabricating about  5.11  of Price To Sales per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmaEngine's earnings, one of the primary drivers of an investment's value.

PharmaEngine Price To Sales vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

PharmaEngine

P/B

 = 

MV Per Share

BV Per Share

 = 
4.72 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

PharmaEngine

P/S

 = 

MV Per Share

Revenue Per Share

 = 
24.13 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

PharmaEngine Price To Sales Comparison

PharmaEngine is currently under evaluation in price to sales category among its peers.

PharmaEngine Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PharmaEngine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PharmaEngine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PharmaEngine's important profitability drivers and their relationship over time.

Use PharmaEngine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmaEngine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will appreciate offsetting losses from the drop in the long position's value.

PharmaEngine Pair Trading

PharmaEngine Pair Trading Analysis

The ability to find closely correlated positions to PharmaEngine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmaEngine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmaEngine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmaEngine to buy it.
The correlation of PharmaEngine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmaEngine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmaEngine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmaEngine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PharmaEngine position

In addition to having PharmaEngine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Blend Funds Thematic Idea Now

Large Blend Funds
Large Blend Funds Theme
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for PharmaEngine Stock Analysis

When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.